Antitumor effects of different administration sequences of cisplatin and Endostar on Lewis lung carcinoma

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 822-828

Spandidos Publications

Access to resources Recommend Favorite

Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer

By                

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 439-445

Spandidos Publications

Access to resources Recommend Favorite

Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models

By            

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 976-980

Spandidos Publications

Access to resources Recommend Favorite

Versican silencing improves the antitumor efficacy of endostatin by alleviating its induced inflammatory and immunosuppressive changes in the tumor microenvironment

By                      

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 2981-2991

Spandidos Publications

Access to resources Recommend Favorite

Recombinant human interleukin-11 improved carboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing Lewis lung carcinoma cells

By Saitoh Minori   Taguchi Katsunari   Momose Kazuhiro   Suga Kazutaka   Yamazaki Noriyuki   Ono Chizuko   Suzuki Tatsuo   Takeuchi Osamu   Yasuda Shuhei   Miyata Keiji  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 161-166

Springer Publishing Company

Access to resources Recommend Favorite